Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. dosikit

DosiKit TERMINATED

DosiKit, a first portable field medical device for fast triage of people after external irradiation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 DosiKit project word cloud

Explore the words cloud of the DosiKit project. It provides you a very rough idea of what is the project "DosiKit" about.

accident    pbi    acubens    changer    scientific    energy    usa    doctors    published    business    starting    instrument    experimented    staff    irradiated    loi    protected    initial    fto    patents    market    validation    transportable    germany    expose    exercise    international    uniting    risk    unmet    competencies    communications    french    final    exposure    tools    medical    actions    partial    2009    critical    responders    nrbc    singapore    worldwide    crisis    validated    sales    fast    young    body    diagnostic    potentially    game    commercialize    dosikit    survey    seasoned    continued    publications    device    exposed    45    reached    biological    founded    2022    booster    regulatory    individuals    dosimetric    irradiation    minutes    radiological    commercial    specialist    atomic    lack    cartography    2014    radiation    prototype    trl6    biodosimetry    2024    care    ip    15    triage    forecasted    oral    schedule    technological    invented    revenue    people    requiring    sme    contact    emergency    nuclear    team    giving    hospitals    undergoing    innovative    managers    classify    initiated    israel    army    armies    fulfil    bio    collaborations    performed   

Project "DosiKit" data sheet

The following table provides information about the project.

Coordinator		 ACUBENS 

Organization address
address: 15 RUE PIERRE GILLES DE GENNES
city: NANTERRE
postcode: 92160
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-08-01   to  2020-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ACUBENS FR (NANTERRE) coordinator 50˙000.00

Map

 Project objective

Acubens was founded in 2014, to develop and commercialize new game-changer medical diagnostic devices around NRBC emergency. Our team gathers young and experimented doctors, and seasoned business managers, uniting their competencies to develop nuclear/radiological/biological innovative transportable biodosimetry devices. Nuclear/radiological accident can expose individuals to radiation, with the need for fast triage of potentially exposed people requiring immediate medical care. There is today a lack of irradiation biodosimetry tools that can be used in the field, by non-specialist staff, giving immediate results and exposure cartography in case of Partial-Body irradiation (PBI). To fulfil this critical unmet need for better initial crisis management, we invented the DosiKit device and fast test (45 minutes) to identify and classify irradiated individuals, directly in the field. This development was initiated in 2009 by the French Atomic Energy Commission within the European Commission program, BOOSTER (‘BiO-dOSimetric Tools for triagE to Responders’), and then continued by Acubens. DosiKit technology is protected by 3 international patents and has reached TRL6 with a prototype validated in a large-scale exercise performed with the French army. Several collaborations are undergoing for biological validation with French research institute and hospitals. Scientific and technical development was published in 3 scientific publications and many international oral communications. A strong contact has established with French, Germany, Israel, US and Singapore armies (LoI). This DosiKit product will be on the market in 2022, starting in Europe and then extending worldwide. Forecasted sales revenue is 15 M€ in 2024. The objectives of this phase 1 SME-Instrument are: (1) the final Biological and Technological validation of the device, (2) IP, FTO, Regulatory and risk assessment studies and (3) a market survey in Europe and USA to schedule our commercial actions.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DOSIKIT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DOSIKIT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  
lastchecktime (2026-09-10 9:51:51) correctly updated